BeCoMe-9: A Phase 1/2 Dose Escalation and Expansion Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B
NCT06611436 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Be Biopharma. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Be Biopharma.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Be Biopharma currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Be Biopharma conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Be Biopharma currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.